1. Home
  2. Southern Africa
  3. South Africa

Lobby group urges cheaper AIDS drugs

A South African AIDS lobby group has lost 100 of its activists to AIDS-related illnesses in a period of just over a four months. The Treatment Action Campaign (TAC) said most of the members who died between March and July 2003 were women younger than 24, and only one was using anti-HIV/AIDS drugs. Zackie Achmat, chairman of the TAC, called on the government to make the drugs more easily accessible to people living with HIV/AIDS by reducing the price to under R200.00 (US $28.53) per month. The drugs currently sell at R300.00 ($42.79) per monthly dose. He said the government could achieve this by issuing licences for the local manufacture of generic versions of the drugs. Achmat was quoted by the South African Press Association (SAPA) as saying: "I am confident the government will act urgently on this. Six hundred people die in our country every day, which is a tragedy. But, even worse is that, there are 1,500 new infections every day."

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join